Next Article in Journal
Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution
Previous Article in Journal
Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy
 
 
Article

Article Versions Notes

Hematol. Rep. 2022, 14(2), 126-134; https://doi.org/10.3390/hematolrep14020019
Action Date Notes Link
article xml file uploaded 8 April 2022 05:49 CEST Original file -
article xml uploaded. 8 April 2022 05:49 CEST Update https://www.mdpi.com/2038-8330/14/2/19/xml
article pdf uploaded. 8 April 2022 05:49 CEST Version of Record https://www.mdpi.com/2038-8330/14/2/19/pdf
article html file updated 8 April 2022 05:50 CEST Original file -
article html file updated 2 August 2022 17:48 CEST Update https://www.mdpi.com/2038-8330/14/2/19/html
Back to TopTop